Whitehawk Therapeutics (WHWK) Other Working Capital Changes (2016 - 2026)
Whitehawk Therapeutics' (WHWK) quarterly Other Working Capital Changes came in at -$89000.0 in Q1 2025, up 29.37% year-on-year from -$68797.5 in Q1 2024, and up 31.01% on a QoQ basis from -$129000.0 in Q4 2024.
Whitehawk Therapeutics (WHWK) Other Working Capital Changes (2016 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 6 years of Other Working Capital Changes data on file, last reported at -$89000.0 in Q1 2025.
- On a quarterly basis, Other Working Capital Changes rose 29.37% year-over-year to -$89000.0 in Q1 2025; TTM through Dec 2025 was -$89000.0, a 82.62% increase from a year earlier, with the FY2025 full-year figure at -$89000.0, up 82.62% from the prior year.
- Other Working Capital Changes for Q1 2025 stood at -$89000.0, up from -$129000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for WHWK reached as high as $1.1 million in Q3 2022 and fell as low as -$1.7 million in Q3 2023.
- Historically, Other Working Capital Changes has averaged -$352352.9 across 5 years, with a median of -$179000.0 in 2024.
- Across the five-year window, Other Working Capital Changes soared 84.31% in 2021 and sank 1412.5% in 2022, its largest moves.
- Year by year, Other Working Capital Changes stood at -$8000.0 in 2021, then sank by 1412.5% to -$121000.0 in 2022, then fell by 4.96% to -$127000.0 in 2023, then declined by 1.57% to -$129000.0 in 2024, then surged by 31.01% to -$89000.0 in 2025.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$89000.0 in Q1 2025, -$129000.0 in Q4 2024, and -$129000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Whitehawk Therapeutics | 256.87 Mn | 45.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.47 Mn |
| Mar 31, 2026 | -1.47 Mn |
| Mar 31, 2026 | -1.47 Mn |
| Dec 31, 2025 | 375,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Dec 31, 2025 | 375,000.00 |
| Sep 30, 2025 | 965,000.00 |
| Sep 30, 2025 | 965,000.00 |
| Sep 30, 2025 | 965,000.00 |
| Jun 30, 2025 | -141,000.00 |
| Jun 30, 2025 | -141,000.00 |
| Jun 30, 2025 | -141,000.00 |
| Mar 31, 2025 | -765,000.00 |
| Mar 31, 2025 | -765,000.00 |
| Mar 31, 2025 | -765,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Sep 30, 2024 | -179,000.00 |
| Sep 30, 2024 | -179,000.00 |